Dendreon's Price Jumps 35% Before Bankruptcy Auction Even Start...

02/05/15


Dendreon's Price Jumps 35% Before Bankruptcy Auction Even Starts
Bloomberg
(Bloomberg) -- The price for Dendreon Corp., the bankrupt developer of a drug to treat advanced prostate cancer, rose more than one-third to $400 million before an auction has even been held. To retain its place as the so-called stalking horse, which ...
Dendreon Enters into Amended Agreement with Valeant in Connection with ...Business Wire (press release)
Valeant Pharma (VRX) Raises 'Stalking Horse' Bid on Dendreon to $400MStreetInsider.com
Valeant Pharmaceuticals Intl Inc (VRX) Approved as Stalking Horse Bidder for ...InvestCorrectly

all 31 news articles »

[more]